Biorce

Biorce

Private
BarcelonaHealthcare & Life Scienceshttps://biorce.com

Last Round

Series A

Feb 2, 2026

Total Funding Raised

$61.5M

Momentum Score

75 /100

Company Overview

Biorce is a healthcare technology company that has developed a clinical AI assistant designed to enhance the speed and cost-efficiency of clinical trials.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Medical AI, Vertical SaaS, Compliance

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

clinical trial automationclintechclinical trial platformclinical trial designtrial feasibility analysisprotocol generationdrug development softwareregulatory planninghealthtech AIexplainable AIclinical trial site selectionpatient recruitment softwareCRO softwareB2B SaaSregtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Biorce Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Biorce Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AFeb 2, 2026
SeedJul 8, 2025
SeedNov 14, 2024

Key People

Founding team and executive leadership

Diogo Pisoeiro

Co-Founder Chief Product Officer

Founding Team

Pedro Coelho

Founder CEO

Founding Team

Biorce Investors

Notable investors and investment history

InvestorRounds
Endeavor CatalystSeries A
DST GlobalSeries A
Mustard Seed MazeSeries A, Seed
Plug and Play Tech CenterSeed
Outsized VenturesSeed
YZR CapitalSeries A, Seed
Norrsken VCSeries A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 18, 2026

    Developing a patient-facing app for clinical trial participants.

  • Apr 18, 2026

    AI-powered data management agent 'NEXUS' for clinical trials.

Biorce Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Biorce Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Biorce's valuation, stock price, and market status.

Firmographic Details

HeadquartersBarcelona
Employee Range72
Year Founded2024
Last FundingFeb 2, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.